NCT00192244View on ClinicalTrials.gov

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children

PHASE3CompletedINTERVENTIONAL

Enrollment

3,000

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

October 31, 2002

Conditions

Healthy

Interventions

BIOLOGICAL

CAIV-T, Liquid

Trial Locations (1)

Unknown

The Prince of Wales Hospital, Hong Kong

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

MedImmune LLC

INDUSTRY